Blueprint Medicines Corp Stock
-
Your prediction
Blueprint Medicines Corp Stock
Pros and Cons of Blueprint Medicines Corp in the next few years
Pros
Cons
Performance of Blueprint Medicines Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | - | - | - | - | - | - | - |
| Ligand Pharmaceuticals | -3.550% | 10.056% | 7.650% | 114.130% | 18.675% | 200.763% | 61.741% |
| United Therapeutics | -0.160% | 0.553% | 4.538% | 95.888% | 14.837% | 135.687% | 188.647% |
| Ionis Pharmaceuticals Inc. | 0.740% | -1.696% | 2.246% | 167.478% | -6.210% | 86.866% | 85.398% |
News
Irresistible Change: How to Spot Real Growth
Phil Gilbert, serial entrepreneur and former general manager at IBM, joins this episode of Motley Fool Money to talk about his new book, Irresistible Change: A Blueprint for Earning Buy-In and
Offshore Titans: Transocean Buys Valaris for $5.8B
Transocean Ltd. (NYSE: RIG) has made the definitive move to cement its status as the undisputed leader in offshore drilling. By agreeing to acquire Valaris Limited (NYSE: VAL) in an all-stock
Why Ford's Deal With Amazon Is Bigger Than You Think
Ford Motor Company (NYSE: F) has made a groundbreaking move in automotive retail, announcing a partnership to sell its certified pre-owned (CPO) vehicles directly on Amazon (NASDAQ: AMZN).
This


